IQVIA™ Real-World Insights Bibliography

Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium. 2R&D China, AstraZeneca R&D, Shanghai, China. 3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo. #Contributed equally.
Publication(s):  BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
Document Type(s): Article,
Countries: Belgium, China,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
A novel decision model to predict the impact of weight management interventions: The Core Obesity Model.
Author(s): Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4
Affiliations(s): 1Novo Nordisk A/S Søborg Denmark. 2IQVIA Zaventem Belgium. 3IQVIA Basel Switzerland. 4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK.
Publication(s):  Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495
Document Type(s): Article,
Countries: Belgium, Switzerland,
Click here for the abstract
C:
Y:
Health economics, Obesity,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publication(s):  European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Type(s): Poster,
Countries: Belgium, France, Germany, Italy, UK,
C:
Y:
Clinical practice, Public Health,
2020
  L:
A:
English
Population Based Study, Public Health, Retrospective database analysis,
  Add to report
 
 
Predictors of iron?deficiency anemia in primary care older adults: a real?world European multi?country longitudinal study
Author(s): Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations(s): Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico ?A. Gemelli?, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publication(s):  Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Type(s): Article,
Countries: Belgium, Germany, Italy, Spain,
Click here for the abstract
C:
Y:
Hematology,
2020
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions
Author(s): Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4
Affiliations(s): 1Novo Nordisk A/S, Søborg, Denmark. snlb@novonordisk.com. 2Novo Nordisk A/S, Søborg, Denmark. 3IQVIA, Zaventem, Belgium. 4Health Economics and Outcomes Research Ltd, Cardiff, UK. 5IQVIA, Basel, Switzerland.
Publication(s):  Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30
Document Type(s): Article,
Countries: Belgium, Denmark, Switzerland, UK,
Click here for the abstract
C:
Y:
Health economics, Obesity,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations(s): 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publication(s):  Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Type(s): Article,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2019
  L:
A:
English
Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study,
  Add to report
 
 
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Author(s): Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations(s): IQVIA, Eli Lilly
Publication(s):  Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Type(s): Article,
Countries: Belgium, Canada, France, Germany, Italy, Netherlands ,
Click here for the abstract
C:
Y:
Diabetes,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Author(s): Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U
Affiliations(s): Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC
Publication(s):  Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
Document Type(s): Article,
Countries: Belgium, France, Germany, Spain, UK,
Click here for the abstract
C:
Y:
Drug safety, Drug Utlization Study,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries
Author(s): Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2
Affiliations(s): 1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy
Publication(s):  Annals of Hematology (2019) 98:1573?1582
Document Type(s): Article,
Countries: Belgium, Germany, Italy, Spain,
C:
Y:
Hematology,
2019
  L:
A:
English
Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study.
Author(s): Meers S1, Bailly B2, Vande Broek I3, Malfait B4, Van Hoorenbeeck S4, Geers J4, Braakman J5, Van Kouwenhove M6, Doyle M7, Diels J8, Caekelbergh K9, Chevalier P9, Dierickx D10.
Affiliations(s): 1 Department Oncology, AZ Klina , Brasschaat , Belgium. 2 Department Haematology, Groupe Jolimont , Haine Saint-Paul , Belgium. 3 Department Oncology, AZ Nikolaas , Haematology, Sint Niklaas , Belgium. 4 Department Market Access, Janssen-Cilag NV , Beerse , Belgium. 5 Department Market Access, Janssen-Cilag BV , Breda , The Netherlands. 6 Department Medical, Janssen-Cilag BV , Breda , The Netherlands. 7 Department Medical, Janssen Ireland , Dublin 24 , Ireland. 8 Department Statistics and Modelling, Janssen Pharmaceutica NV , Beerse , Belgium. 9 Department Real-World Solutions, IQVIA , Zaventem , Belgium. 10 Department Haematology, UZ Leuven , Leuven , BelgiumDepartment Haematology.
Publication(s): 
Document Type(s): Abstract,
Countries: Belgium,
Click here for the abstract
C:
Y:
Infectious disease, Oncology,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
 1 of 15 Next Page Last Page